Harry C. Schouten

19.6k total citations · 3 hit papers
182 papers, 9.9k citations indexed

About

Harry C. Schouten is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Harry C. Schouten has authored 182 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Hematology, 65 papers in Oncology and 42 papers in Pathology and Forensic Medicine. Recurrent topics in Harry C. Schouten's work include Hematopoietic Stem Cell Transplantation (43 papers), Lymphoma Diagnosis and Treatment (40 papers) and Acute Myeloid Leukemia Research (36 papers). Harry C. Schouten is often cited by papers focused on Hematopoietic Stem Cell Transplantation (43 papers), Lymphoma Diagnosis and Treatment (40 papers) and Acute Myeloid Leukemia Research (36 papers). Harry C. Schouten collaborates with scholars based in Netherlands, France and United States. Harry C. Schouten's co-authors include J.M. de Rijke, M.H.J. van den Beuken-van Everdingen, Maarten van Kleef, J. Patijn, A. G. H. Kessels, Bob Löwenberg, Leo F. Verdonck, Pieter Sonneveld, Aloïs Gratwohl and Johan Maertens and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Harry C. Schouten

178 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of pain in patients with cancer: a systematic review of the past 40 years

2007 1.4k citations Harry C. Schouten et al. Annals of Oncology profile →
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

2009 596 citations Bob Löwenberg, Gert J. Ossenkoppele et al. profile →
Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

1999 525 citations Jakob Passweg, Harry C. Schouten et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harry C. Schouten Netherlands	46	4.2k	3.4k	2.0k	1.7k	1.7k	182	9.9k
Lisa Rybicki United States	57	1.5k 0.4×	4.3k 1.3×	1.8k 0.9×	1.7k 1.0×	1.9k 1.2×	408	13.0k
Martin M. Oken United States	47	4.0k 0.9×	7.4k 2.2×	1.8k 0.9×	3.2k 2.0×	3.6k 2.2×	145	18.2k
Vibeke Strand United States	73	5.6k 1.3×	1.5k 0.5×	969 0.5×	2.6k 1.6×	1.5k 0.9×	522	22.9k
John T. Sandlund United States	60	3.4k 0.8×	2.3k 0.7×	5.8k 2.9×	1.7k 1.1×	1.7k 1.0×	169	10.5k
Orhan Sezer Germany	58	3.9k 0.9×	5.2k 1.5×	509 0.3×	990 0.6×	4.6k 2.8×	171	11.0k
Sy Ha China	53	4.2k 1.0×	2.6k 0.8×	1.1k 0.5×	750 0.5×	1.4k 0.8×	341	14.3k
Mark F. Munsell United States	64	779 0.2×	3.6k 1.1×	1.0k 0.5×	1.5k 0.9×	2.0k 1.2×	243	11.8k
Jeffrey L. Johnson United States	63	720 0.2×	1.9k 0.6×	1.2k 0.6×	2.2k 1.3×	907 0.5×	266	13.3k
Eleanor McFadden United States	11	598 0.1×	5.0k 1.5×	1.2k 0.6×	1.1k 0.7×	865 0.5×	13	10.1k
Douglass C. Tormey United States	33	643 0.2×	6.5k 1.9×	1.4k 0.7×	1.7k 1.0×	1.7k 1.0×	87	14.3k

Countries citing papers authored by Harry C. Schouten

Since Specialization

Citations

This map shows the geographic impact of Harry C. Schouten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry C. Schouten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry C. Schouten more than expected).

Fields of papers citing papers by Harry C. Schouten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry C. Schouten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry C. Schouten. The network helps show where Harry C. Schouten may publish in the future.

Co-authorship network of co-authors of Harry C. Schouten

This figure shows the co-authorship network connecting the top 25 collaborators of Harry C. Schouten. A scholar is included among the top collaborators of Harry C. Schouten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry C. Schouten. Harry C. Schouten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lieshout, Rianne van, Lidwine W. Tick, Harry R. Koene, et al.. (2023). Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists’ experiences and perspectives. Clinical Nutrition ESPEN. 57. 399–409. 1 indexed citations

Köhler, Sebastian, et al.. (2022). Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA). Annals of Hematology. 102(3). 641–649. 3 indexed citations

Köhler, Sebastian, et al.. (2022). Assessing long-term effects after stem cell transplantation: design of the MOSA study. Journal of Clinical Epidemiology. 148. 10–16. 3 indexed citations

Meulen, Matthijs van der, Linda Dirven, Esther J. J. Habets, et al.. (2021). Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial. Neuro-Oncology. 23(8). 1315–1326. 9 indexed citations

Díaz‐Beyá, Marina, Myriam Labopin, Johan Maertens, et al.. (2020). Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission. British Journal of Haematology. 189(5). 920–925. 14 indexed citations

Harrison, Claire, Nicolaas Schaap, Alessandro M. Vannucchi, et al.. (2020). Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure. American Journal of Hematology. 95(6). 594–603. 104 indexed citations

Leader, Avi, Vincent ten Cate, Arina J. ten Cate‐Hoek, et al.. (2020). Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment. European Journal of Internal Medicine. 77. 86–96. 7 indexed citations

Sureda, Anna, Mei‐Jie Zhang, Peter Dreger, et al.. (2018). Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR. Cancer. 124(8). 1733–1742. 40 indexed citations

Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2018). Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission. American Journal of Hematology. 94(2). 231–239. 13 indexed citations

10.

Ruggeri, Annalisa, Myriam Labopin, Andrea Bacigalupo, et al.. (2018). Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT. Journal of Hematology & Oncology. 11(1). 40–40. 97 indexed citations

11.

Ruggeri, Annalisa, Myriam Labopin, Boris V. Afanasyev, et al.. (2017). Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT. Blood. 130. 215–215. 6 indexed citations

12.

Martino, Massimo, Francesco Lanza, Lorenzo Pavesi, et al.. (2015). High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry. Biology of Blood and Marrow Transplantation. 22(3). 475–481. 4 indexed citations

13.

Heinen, Mirjam M., Piet A. van den Brandt, Leo J. Schouten, et al.. (2014). Dietary One-Carbon Nutrient Intake and Risk of Lymphoid and Myeloid Neoplasms: Results of the Netherlands Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 23(10). 2153–2164. 1 indexed citations

14.

Potting, Carin, Walter J. F. M. van der Velden, Koen Theunissen, et al.. (2012). Caphosol in prevention of oral mucositis in autologous stem cell transplant recipients after high-dose melphalan (CASH). Bone Marrow Transplantation. 47. 2 indexed citations

15.

Kampen, Roel J.W. van, Carmen Canals, Harry C. Schouten, et al.. (2011). Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry. Journal of Clinical Oncology. 29(10). 1342–1348. 141 indexed citations

16.

Kellen, Eliane, et al.. (2010). Identifying an accurate pre-screening tool in geriatric oncology. Critical Reviews in Oncology/Hematology. 75(3). 243–248. 75 indexed citations

17.

Cornelissen, Jan J., Bronno van der Holt, Gregor Verhoef, et al.. (2008). Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood. 113(6). 1375–1382. 121 indexed citations

18.

Cornelissen, Jan J., Wim L.J. van Putten, Leo F. Verdonck, et al.. (2007). Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?. Blood. 109(9). 3658–3666. 345 indexed citations

19.

Tiel, Frank H. van, et al.. (2007). Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety. Annals of Oncology. 18(6). 1080–1084. 41 indexed citations

20.

Hupperets, P., Lex Volovics, Leo J. Schouten, et al.. (1997). The Prognostic Significance of Steroid Receptor Activity in Tumor Tissues of Patients with Primary Breast Cancer. American Journal of Clinical Oncology. 20(6). 546–551. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact